Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Pavel A. Anistratov"'
Autor:
Natalia M. Maschenko, Lyudmila Ya. Rozenko, Aleksey N. Shevchenko, Olga V. Kozyuk, Mikhail S. Zinkovich, Tamara G. Airapetova, Pavel А. Anistratov, Dmitry V. Burtsev, L.N. Vaschenko, Galina V. Zhukova, Alla I. Shikhlyarova, Marina А. Gusareva, Elena А. Shirnina
Publikováno v:
Cardiometry, Iss 13 (2018)
Aim The aim hereof is a comprehensive study of the mental, adaptive and hormonal status in patients with lung cancer with varying prevalence of the malignant process. The obtained results are compared with data on the psychosomatic state and subclini
Autor:
Irina V. Neskubina, Elena M. Frantsiyants, Ekaterina I. Surikova, Irina V. Kaplieva, Lyubov К. Trepitaki, Lyudmila А. Nemashkalova, Yulia A. Pogorelova, Alla I. Shikhlyarova, Galina V. Zhukova, Pavel N. Anistratov, Viktoria L. Volkova, Natalia А. Chertova, Oksana E. Zhenilo, Anna А. Cherkasova, Olga G. Selezneva
Publikováno v:
Cardiometry, Iss 13 (2018)
Aim The aim hereof is to study the glutathione system peculiarities in the cardiac mitochondria in experimental animals against the background of a tumor process, chronic pain and the combined effect both of chronic pain and the tumor process. Materi
Autor:
Igor N. Turkin, Yuriy N. Lazutin, Oleg N. Stateshny, Anna V. Chubaryan, Igor A. Leyman, Oleg I. Kit, M. A. Gappoeva, Denis S. Kutilin, Pavel A. Anistratov
Publikováno v:
Journal of Clinical Oncology. 37:e14502-e14502
e14502 Background: Currently known markers of lung adenocarcinoma are insufficient to predict the development of this disease, which makes the search for new molecular markers a relevant problem. Our purpose was to analyze changes in genes copy numbe
Autor:
Anna V. Chubaryan, Oleg N. Stateshny, Pavel A. Anistratov, Dmitry I. Vodolazhsky, Oleg I. Kit, Yuriy N. Lazutin, Denis S. Kutilin, Igor A. Leyman, Sergey P. Pyltsin, Igor N. Turkin, Tamara G. Ayrapetova
Publikováno v:
Journal of Clinical Oncology. 36:e24060-e24060
e24060Background: The problem of early diagnosis of lung cancer remains unsolved since currently known molecular markers for lung cancer diagnosis do not possess necessary specificity. Studying gen...
Autor:
Oleg N. Stateshny, Sergey P. Pyltsin, M. Afaunov, Igor A. Leyman, S. G. Beleckiy, A. S. Shogenov, Anna V. Chubaryan, Tamara G. Ayrapetova, M. A. Gappoeva, Liubov Yu Vladimirova, Yuri Lazutin, Igor N. Turkin, Rukiyat Isaeva, Pavel A. Anistratov
Publikováno v:
Journal of Clinical Oncology. 36:8534-8534
8534Background: The purpose of the study was to compare the results of neoadjuvant polychemoimmunotherapy (nPCIT) and conventional neoadjuvant polychemotherapy (nPCT) in patients with NSCLC. Method...
Autor:
Oleg N. Stateshny, Liubov Yu Vladimirova, A. S. Shogenov, Igor N. Turkin, Yuri Lazutin, M. A. Gappoeva, Rukiyat Isaeva, M. Afaunov, Tamara G. Ayrapetova, S. G. Beleckiy, Pavel A. Anistratov, Igor A. Leyman, Sergey P. Pyltsin, Anna V. Chubaryan
Publikováno v:
Journal of Clinical Oncology. 36:e24323-e24323
e24323Background: The purpose of the study was to reveal morphological changes in tissues of NSCLC after various nPCT regimens. Methods: The study included 64 pts with stage IIb-IIIa NSCLC divided ...
Autor:
A. S. Shogenov, Andrey Vladimirovich Bakhtin, Tamara G. Ayrapetova, Galina I. Zakora, Inna Arnoldovna Novikova, Olesya N. Selyutina, M. A. Gappoeva, M. Kh. Afaunov, Pavel A. Anistratov, Elena Yurievna Zlatnik, Sergey P. Pyltsin, Anna V. Chubaryan, Yuriy N. Lazutin, Igor A. Leyman
Publikováno v:
Journal of Clinical Oncology. 35:e20018-e20018
e20018 Background: The purpose of the study was to evaluate parameters of cellular immunity in lung cancer patients with various levels of circulating tumor cells (CTCs) and different tumor histogenesis. Methods: Blood samples of 28 patients (24 men,
Autor:
Igor A. Leyman, M. Kh. Afaunov, Yuriy N. Lazutin, M. A. Gappoeva, Pavel A. Anistratov, Tamara G. Ayrapetova, A. S. Shogenov, Anna V. Chubaryan, Sergey P. Pyltsin
Publikováno v:
Journal of Clinical Oncology. 35:e20090-e20090
e20090 Background: We performed a comparative analysis of disease-free survival (DFS) after adjuvant chemoimmunotherapy (ACIT) with recombinant interferon-gamma in combination therapy and standard adjuvant chemotherapy (ACT) of patients with acinar-t
Autor:
Maxim N. Dyritsky, Vyacheslav A. Sustretov, Denis S. Kutilin, Oleg I. Kit, Dmitriy I. Vodolazhsky, Pavel A. Anistratov, Tamara G. Ayrapetova, Yaroslav S. Enin, Igor N. Turkin, Anna V. Chubaryan, Sergey P. Pyltsin, Igor A. Leyman, Leonid V. Kharin, Olesia A. Bogdanova
Publikováno v:
Journal of Clinical Oncology. 35:e23094-e23094
e23094 Background: Today, the problem of early diagnostics of lung cancer remains unsolved as every fourth patient diagnosed with the disease already has distant metastases. Studying gene copy number variation (CNV) in extracellular DNA in the blood
Autor:
M. Kh. Afaunov, Anna Pavlovna Kharitonova, M. A. Gappoeva, Igor A. Leyman, Anna V. Chubaryan, A. S. Shogenov, Sergey P. Pyltsin, Yuriy N. Lazutin, Pavel A. Anistratov, Tamara G. Ayrapetova
Publikováno v:
Journal of Clinical Oncology. 35:e20064-e20064
e20064 Background: Induction chemotherapy (iCT) for NSCLC has potential advantages over adjuvant CT, high therapeutic compliance, the ability to influence the primary tumor and metastatic disease. Standard approaches to iCT improving are largely exha